Keywords: astrazeneca, zomig, impresses, cluster, headache, trial, anglo-swedish

AstraZeneca's Zomig impresses in cluster headache trial

Article | 09 July 2007

Print This

Anglo-Swedish drug major AstraZeneca says that data from a study of its pain treatment Zomig (zolmitriptan) shows that the drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in